VLP Therapeutics Biotech

Funding, team structure (meet the founders), partners and clients

undefined logo
Market - Biotech
Description - 日本医療研究開発機構 (AMED) が公募する「新型コロナウイルス感染症(COVID-19)に対するワクチン開発」(2次公募)への採択のお知らせ SEE OUR TECHNOLOGY Our Clinical Trial Our malaria vaccine candidate VLPM01 clinical trial designed to evaluate the safety, tolerability, immunogenicity and experimental efficacy of VLPM01 in healthy,

Team

Founder Wataru Akahata
Founder

Funding

VLP Therapeutics raised $16,000,000 with LLC and MIYAKO Capital Co and Sojitz Corporation - 3/22/2021